Current Report Filing (8-k)
October 29 2020 - 04:08PM
Edgar (US Regulatory)
0000944809false00009448092020-10-292020-10-29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934
Date of Report (Date of earliest event reported): October 29,
2020
OPKO Health, Inc.
(Exact Name of Registrant as Specified in its Charter)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware |
|
001-33528 |
|
75-2402409 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4400 Biscayne Blvd. |
Miami, |
Florida |
|
33137 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code:
(305) 575-4100
|
|
|
Not Applicable |
Former name or former address, if changed since last
report |
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
|
|
|
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Common Stock, par value $0.01 per share |
OPK |
NASDAQ Global Select Market |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
|
|
|
|
|
|
|
|
|
ITEM 2.02.
|
|
Results of Operations and Financial Condition. |
On October 29, 2020, OPKO Health, Inc. (the “Company”) issued a
press release announcing operating and financial highlights for the
quarter ended September 30, 2020. In the press release, the Company
also provided information with respect to the conference call it is
hosting to provide a business update and discuss its third quarter
ended September 30, 2020 financial and operating results, as well
as discuss financial guidance. A copy of the press release is
attached hereto as Exhibit 99.1.
The information included herein and in Exhibit 99.1 shall not be
deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (“Exchange Act”) or otherwise
subject to the liabilities of that section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of
1933 as amended or the Exchange Act, except as expressly set forth
by specific reference in such a filing.
|
|
|
|
|
|
|
|
|
ITEM 9.01.
|
|
Financial Statements and Exhibits.
|
|
|
|
|
|
|
|
|
|
Exhibit No. |
|
Description |
|
|
99.1 |
|
Press Release of the Company dated October 29, 2020 |
104 |
|
Cover Page Interactive Data File-the cover page XBRL tags are
embedded within the Inline XBRL document |
Exhibit Index
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit No. |
|
Description |
|
|
99.1 |
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly
authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPKO Health, Inc.
|
|
|
|
|
|
|
By:
|
/s/ Adam Logal
|
Date: October 29, 2020
|
|
Name:
|
Adam Logal
|
|
|
Title:
|
Senior Vice President, Chief Financial Officer
|
|
|
|
|
Opko Health (NASDAQ:OPK)
Historical Stock Chart
From Dec 2020 to Jan 2021
Opko Health (NASDAQ:OPK)
Historical Stock Chart
From Jan 2020 to Jan 2021